OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.

Piper said it met with Axsome’s senior management recently, and gained more insights into commercial dynamics surrounding ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Human history was forever changed with the discovery of antibiotics in 1928. Infectious diseases such as pneumonia, tuberculosis and sepsis were widespread and lethal until antibiotics made them ...

Scientists have used AlphaFold 3 to identify a potential new drug target to treat monkeypox virus. With the help of artificial intelligence (AI), an international team of researchers has made the ...

Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...